PACOR, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 9.019
EU - Europa 6.616
AS - Asia 2.091
SA - Sud America 216
AF - Africa 35
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
Totale 18.002
Nazione #
US - Stati Uniti d'America 8.973
PL - Polonia 1.669
SE - Svezia 956
DE - Germania 855
IT - Italia 822
SG - Singapore 734
UA - Ucraina 706
CN - Cina 582
HK - Hong Kong 419
RU - Federazione Russa 389
FI - Finlandia 236
GB - Regno Unito 232
TR - Turchia 212
BR - Brasile 186
FR - Francia 152
BG - Bulgaria 125
IE - Irlanda 121
NL - Olanda 109
BE - Belgio 51
CH - Svizzera 50
BY - Bielorussia 42
CA - Canada 32
VN - Vietnam 27
AT - Austria 23
KR - Corea 15
PK - Pakistan 15
SN - Senegal 15
AR - Argentina 13
BA - Bosnia-Erzegovina 13
IN - India 12
RO - Romania 12
CZ - Repubblica Ceca 10
AU - Australia 9
JP - Giappone 9
EU - Europa 8
PT - Portogallo 8
HR - Croazia 7
ID - Indonesia 7
MX - Messico 7
RS - Serbia 7
IR - Iran 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
BD - Bangladesh 5
EC - Ecuador 5
VE - Venezuela 5
ES - Italia 4
IQ - Iraq 4
KZ - Kazakistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
NO - Norvegia 3
SI - Slovenia 3
TW - Taiwan 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
AZ - Azerbaigian 1
BZ - Belize 1
CM - Camerun 1
CO - Colombia 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TM - Turkmenistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.002
Città #
Warsaw 1.652
Ann Arbor 1.188
Woodbridge 1.067
Fairfield 856
Houston 852
Chandler 700
Jacksonville 618
Ashburn 525
Wilmington 458
Hong Kong 419
Singapore 384
Seattle 359
Trieste 291
Cambridge 281
Princeton 229
Boardman 226
Izmir 194
Beijing 165
Columbus 132
Sofia 125
Dearborn 120
Dublin 119
Moscow 102
Düsseldorf 68
Santa Clara 64
San Diego 57
The Dalles 48
Brussels 46
Frankfurt am Main 45
Milan 45
Bern 37
Falls Church 33
North Bergen 29
Guangzhou 27
Helsinki 27
Los Angeles 27
Chicago 26
Bremen 25
Mestre 25
Redwood City 25
Shanghai 24
Buffalo 22
Norwalk 21
São Paulo 21
Kunming 20
Des Moines 19
Hefei 19
Nanjing 19
Verona 19
Dong Ket 18
Sacile 17
Vienna 17
Grafing 16
Phoenix 16
Dakar 15
Jinan 15
Ottawa 15
Amsterdam 14
Nuremberg 14
Redmond 14
Munich 13
Sarajevo 13
Seoul 12
Shenyang 12
Toronto 12
Washington 12
Dallas 11
Kocaeli 11
Lauterbourg 10
Manzano 10
Wroclaw 10
Auburn Hills 9
Roubaix 9
Council Bluffs 8
New York 8
Rio de Janeiro 8
Rivalta 8
Rome 8
Udine 8
Andover 7
Bologna 7
Chengdu 7
Hanoi 7
Nanchang 7
Stockholm 7
Tokyo 7
Brno 6
Falkenstein 6
Fuzhou 6
Hebei 6
Múggia 6
Campinas 5
Fano 5
Fremont 5
Hangzhou 5
Padova 5
Palermo 5
Portsmouth 5
San Jose 5
Taunsa 5
Totale 12.387
Nome #
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 444
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 416
Arabica coffee extract shows antibacterial activity against Staphylococcus epidermidis and Enterococcus faecalis and low toxicity towards a human cell line 398
Effects of gold nanoparticles, protected by self-assembling mixtures of ligands, on eukaryotic cells and model membranes 361
HIV Protease Inhibitors Apoptotic Effect in SH-SY5Y Neuronal Cell Line 343
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine 325
Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives 305
Insights on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 294
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 291
Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing 269
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. 243
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. 228
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 218
Apoptotic pathways of U937 leukemic monocytes investigated by infrared microspectroscopy and flow cytometry 199
Mixed Fluorinated/Hydrogenated Self-Assembled Monolayer-Protected Gold Nanoparticles: In Silico and In Vitro Behavior 197
The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage 191
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 186
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 185
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 184
Antifungal Activity of Amphotericin BConjugated to Carbon Nanotubes 182
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 181
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 180
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 178
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 175
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 174
Optimization of microfluidic systems for IRMS long term measurement of living cells 174
Ruthenium(III) complexes as antineoplastic agents. 172
Synthetic antimicrobial peptides designed from sequence templates 172
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 172
Dual mode of action of Bac7, a proline-rich antibacterial peptide 171
Rapid and reliable detection of antimicrobial peptide penetration into Gram-negative bacteria based on fluorescence quenching. 171
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): Toward a powerful label-free cell-based assay 170
Structure dependence of biological activities for primate cathelicidins. 168
Photobiomodulation therapy promotes in vitro wound healing in nicastrin KO HaCaT cells 168
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 167
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852) 166
Multivalent, mixed self-assembled monolayer protected gold nanoparticles: from design to biological application 166
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 165
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37 163
Primate beta-defensins--structure, function and evolution. 160
Primate cathelicidin orthologues display different structures and membrane interactions 158
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 155
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 155
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 154
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 153
Synchrotron radiation infrared microspectroscopy of single living cells in microfluidic devices: Advantages, disadvantages and future perspectives 152
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 151
Mast cell activation by myelin through scavenger receptor. 150
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 150
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 149
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 148
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 146
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 146
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 144
Lysozyme induced recovery of the response to ConA on mononuclear cells harvested from mice bearing MCa mammary carcinoma 143
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 142
Tumour metastatic potential after treatment with selective antimetastatic drugs 141
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 139
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity 137
Galectin-1 in cartilage: expression and influence on chondrocytes growth and interaction with ECM components 137
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 137
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 135
Computational and experimental investigation on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 135
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 133
Bacillus cereus cell and spore properties as influenced by the micro-structure of the medium 131
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 129
Recovery of lymphocyte CD4+:CD8+ ratio in patients treated with lysozyme 128
DON'T JUDGE A BOOK BY ITS COVER: JANUS AND STRIPED SAM-PROTECTED GOLD NANOPARTICLES AT THE NANO-BIO INTERFACE 128
Biological and technological evaluation of PVC containers for human blood and blood components 127
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 127
Mechanism of tumor inhibition by the metal complex trans-RuCl2(dimethylsulphoxide)4 127
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 127
Fabrication of a microfluidic platform for investigating dynamic biochemical processes in living samples by FTIR microspectroscopy 124
Modification of growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides 124
Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2 122
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 122
null 120
null 120
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 120
Infrared microspectroscopy of biochemical response of living cells in microfabricated devices 120
Cytofluorimetric analysis of gut-intraepitelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme 120
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 120
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 118
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. 117
Water soluble ruthenium(III)-dimethyl sulfoxide complexes: chemical behaviour and pharmacological properties 116
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma 115
In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative 111
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 110
Structure-activity relationship study on Bac7(1-35), a synthetic fragment of the Pro-rich antibacterial peptide Bac7 108
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 108
Effects of the Ru(III) complexes mer-RuCl3(DMSO)2Im and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors. 107
[1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines 102
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph nodelymphocytes of tumour bearing mice fed with egg-white lysozyme. 102
Hematologic effects of oral treatment with lysozyme chloride: a phase-II study 101
Influence of agar content on the growth parameters of Bacillus cereus. 100
Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells. 100
Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas 100
Inhibition of carrageenin paw edema by pyridinalalkylimine rhodium(I) complexes 99
Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma 97
null 97
Totale 16.506
Categoria #
all - tutte 50.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020373 0 0 0 0 0 0 0 0 0 0 245 128
2020/20212.023 215 96 176 300 137 237 139 155 103 210 69 186
2021/20221.673 56 113 123 230 32 137 80 50 172 188 108 384
2022/20232.081 210 287 161 314 188 363 7 179 215 20 78 59
2023/20241.084 97 70 73 71 108 71 163 221 22 29 91 68
2024/20252.485 49 117 196 282 276 288 272 168 390 361 86 0
Totale 18.482